Eloxx Pharmaceuticals, Inc. (ELOX)
Develops drugs that fix genetic diseases caused by faulty stop signals in DNA.
$12.81+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-5.3%
The outlook
ELOX trades at $12.81, positioned midway in its 52-week range and above both its 50- and 200-day moving averages. The two analysts covering the stock both rate it Strong Buy, with an average price target about 224% above the current level. The overall data reflects a bullish technical setup paired with notably optimistic analyst sentiment.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendAbove its 50- & 200-day averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +224% vs current price
Analyst price target
~12-month · 2 analysts$41.50average target+224.0% vs now
Now $12.81
Low $40.00High $43.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$44.0M
52-wk high
$17.50
52-wk low
$8.20
50-day avg
$12.30
200-day avg
$12.30
Trailing P/E
—